Cambridge, MA, United States of America

Mark Andrew Fleming

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Winchester, MA (US) (2009)
  • Cambridge, MA (US) (1999 - 2010)

Company Filing History:


Years Active: 1999-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Andrew Fleming

Introduction

Mark Andrew Fleming, an accomplished inventor based in Cambridge, MA, has made significant strides in the field of biochemistry through his work. With a remarkable portfolio of six patents, he has contributed to advancements that enhance our understanding of protein structures and their interactions.

Latest Patents

Among his latest patents is the groundbreaking work on the "Crystal structure of Rho-kinase I kinase domain complexes and binding pockets thereof." This invention focuses on the human Rho-kinase I (ROCK I), its binding pockets, and the development of computer systems capable of storing and utilizing structural coordinates for research. His work allows for the identification and design of compounds, including inhibitors, that can effectively interact with the ROCK I protein.

Another innovative patent, "Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid," deals with data storage mediums that visualize the binding pockets of IMPDH on computer screens. This invention aids in solving the structures of homologous proteins and assists in compound design, including pharmaceutical compositions aimed at inhibiting IMPDH.

Career Highlights

Mark Andrew Fleming has established a prominent career at Vertex Pharmaceuticals, an influential company in the biotechnology sector. His work at Vertex is characterized by a focus on developing novel therapeutic approaches through innovative research and experimentation.

Collaborations

Throughout his career, Fleming has collaborated with esteemed colleagues, including Keith P. Wilson and Michael D. Sintchak. These partnerships have allowed him to leverage collective expertise and knowledge, further enhancing the impact of his inventions in scientific research.

Conclusion

In summary, Mark Andrew Fleming stands out as an inventive force in the field of biochemistry. His six patents reflect not only his expertise but also his commitment to pushing the boundaries of scientific discovery. Through his work at Vertex Pharmaceuticals and collaborations with leading scientists, Fleming continues to contribute meaningfully to advancements that have the potential to reshape therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…